WednesdayNov 10, 2021 12:15 pm

InMed Pharmaceuticals Inc. (NASDAQ: INM) Files International Patent Application for Treating Neurodegenerative Diseases Using a New Rare Cannabinoid 

InMed Pharmaceuticals has filed an international patent application that specifies a rare cannabinoid that may inhibit or slow the progression of neurodegenerative disease and potentially enhance the neuronal function With neurogenerative diseases affecting millions worldwide and the cost of treating patients expected to rise in the future, finding treatments and cures is a matter of increasing urgency InMed’s patent application is a promising start, expanding the company’s patent portfolio, which currently includes twelve patent families InMed Pharmaceuticals (NASDAQ: INM), a global leader in the manufacturing and pharmaceutical development of rare cannabinoids, recently filed a Patent Cooperation Treaty (“PCT”) application, titled…

Continue Reading

WednesdayNov 10, 2021 11:24 am

Sugarmade Inc. (SGMD) Looks to Leverage Expertise as It Eyes Projected Double-Digit CAGR Growth

Global cannabis market estimated to reach $19.89 billion in 2021, projected to grow at a CAGR of 27% North America projected to record the highest market share during the forecast period SGMD is expanding role as a central player in growing California cannabis delivery marketplace, developing in-house cannabis production capacity As growing numbers of consumers around the world become more aware of the potential benefits of cannabis, the market is projected to see significant growth. A new report notes that the global cannabis market is estimated to grow at a CAGR of 27.0% from 2021 to 2030 (https://cnw.fm/KHrYH). That anticipated…

Continue Reading

MondayNov 08, 2021 1:59 pm

Simply Sonoma Inc. Looking to Establish Strong Presence in Growing CBD Skin-Care Market

The CBD skin-care sector has been projected to reach $1.7 billion by 2025 Market growth has been driven by rising awareness about the benefits of CBD-infused beauty products. Simply Sonoma anticipates releasing an array of face and skin creams, moisturizers and beauty products. Interest in cannabidiol, or CBD, is exploding as the substance has been shown to have myriad benefits. A chemical derived from cannabis, CBD has been included in everything from gummies to dog treats and more. One of the sectors showing impressive potential is skin care, a market that has been projected to reach $1.7 billion by 2025…

Continue Reading

MondayNov 08, 2021 11:59 am

Sugarmade Inc. (SGMD) Continues Commitment to Excellence as Cannabis Bill Creates State Regulatory Framework

Assembly Bill 45 provide clarity for the hemp industry and reassures consumers that products are independently tested and labeled properly Bill allows the sale of hemp-derived extracts that comply with testing and labeling standards SGMD, Nug Avenue committed to providing convenient mobile ordering and online access to its exclusive, quality products Keeping in line with its reputation for leading the way forward in cannabis acceptance and legislation, California lawmakers and government officials have approved an historic hemp bill (https://cnw.fm/9RsrZ). The bill — Assembly Bill 45 (AB-45) — creates a comprehensive regulatory framework for the manufacture and sale of hemp-derived products in…

Continue Reading

FridayNov 05, 2021 10:51 am

German Cannabis Market Expected to Liberalize Post Election, RYAH Group Inc. (CSE: RYAH) Enters Germany Via Observational Study

German Social Democrat-led coalition expected to liberalize medical cannabis market  Analysts predict over one million medical cannabis patients in Germany by 2024, market estimated to reach $8.9 billion by 2028 RYAH entered German market via observational study with Four 20 Pharma GmbH RYAH provides IoT product ecosystem of volume-control devices, medicine-carrying components, mobile applications RYAH ecosystem offers reliable way for researchers and clinicians to develop well-controlled research environments Germany’s recent 2021 election is expected to result in a new political environment via a coalition containing cannabis-positive political factions that aim to liberalize the country’s plant-based medicine market (https://cnw.fm/z1BxY). RYAH Group…

Continue Reading

WednesdayNov 03, 2021 1:44 pm

The Cannabis World Congress & Business Exposition (CWCBExpo) Is Set to Headline the New York Cannabis Week; Will Bring Together Hundreds of Businesses from Across the Cannabis Ecosystem

The Cannabis World Congress & Business Exposition (CWCBExpo) will be held in New York between November 4-6, 2021 The conference will feature over 50 expert speakers, in addition to hundreds of exhibitors showcasing the sector’s latest product innovations Recent forecasts have estimated overall US marijuana retail sales to rise from $20 billion in 2020 to $38.4-45.9 billion by 2025 The Cannabis World Congress & Business Exposition (“CWCBExpo”) event is set to be held at New York City’s Javits Convention Center, Hall 3A between 4-6 November 2021. Set to be held during Cannabis Week, a weeklong event taking place between Monday…

Continue Reading

WednesdayNov 03, 2021 12:38 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Commences New Animal Study Evaluating Patented DehydraTECH(TM) Technology’s Efficacy in Reducing/Inhibiting Seizure Activity; Strengthens IP Portfolio

Lexaria recently announced the commencement of EPIL-A21-1, an animal study to evaluate whether DehydraTECH-CBD has similar or superior efficacy in reducing or inhibiting seizure activity compared to FDA-approved seizure drug, Epidiolex The study will also compare DehydraTECH-CBD to generic CBD EPIL-A21-1 has entered early-stage preparatory work, with results expected in Q3 2022 Lexaria received new patent awards in Mexico and Japan, strengthening its IP portfolio to 23 granted patents Lexaria Bioscience (NASDAQ: LEXX), the drug delivery platform innovator behind the disruptive, patented DehydraTECH(TM) technology, recently announced it had commenced an important new animal study, EPIL-A21-1 (https://cnw.fm/iMVe3). EPIL-A21-1, which will be…

Continue Reading

TuesdayNov 02, 2021 12:59 pm

Cannabis Strategic Ventures Inc. (NUGS) Is ‘One to Watch’

Cannabis Strategic Ventures’ 2020 revenue jumped 517% year-over-year to $14.6 million 2020 revenues from cannabis sales were $14.1 million, up 975% compared to fiscal 2019 The company’s gross profit spiked 483% year-over-year, reaching $2.78 million in 2020, while gross margins held steady at about 20 percent Cannabis Strategic Ventures will launch its first Los Angeles dispensary in Q4 2021 The company will open an indoor cultivation facility with capacity to produce up to 15,000 pounds of premium cannabis flower annually Cannabis Strategic Ventures (OTC: NUGS) is an emerging leader in the U.S. cannabis marketplace as a publicly traded cannabis cultivator.…

Continue Reading

MondayNov 01, 2021 1:49 pm

Successful Ginkgo Bioworks SPAC IPO Highlights Available Industry Opportunities for InMed Pharmaceuticals Inc. (NASDAQ: INM) and Synthetic Cannabinoid Production

Special purpose acquisition company Soaring Eagle Acquisition Corp. combined with Ginkgo Bioworks to form publicly listed Ginkgo Bioworks Holdings Inc., in what is the largest-ever biotechnology go-public transaction Ginkgo Bioworks is known for its work in the commercial-scale production of a rare cannabinoid, CBG, for use in a multitude of industrial needs InMed uses multiple manufacturing approaches to synthetically produce rare cannabinoids, including CBC which is currently sold through its subsidiary BayMedica The success of the Ginkgo IPO suggests the marketplace value associated with the production of rare cannabinoids  Special purpose acquisition company (“SPAC”) Soaring Eagle Acquisition Corp. (NASDAQ: SRNGU,…

Continue Reading

MondayNov 01, 2021 11:49 am

The Cannabis World Congress & Business Exposition (‘CWCBExpo’) Establishes Itself as a Key Forum for Establishing a Foothold Within New York’s Burgeoning Cannabis Sector

New York’s recreational marijuana market is poised to begin with a bang — and the Cannabis World Congress & Business Exposition (“CWCBExpo”), which is being held at New York City’s Javits Convention Center, Hall 3A between 4-6 November 2021, is the ideal forum for education, business building and networking on this multifaceted industry. As of Sept. 21, 2021, adult New Yorkers are now able to possess up to three ounces of cannabis for recreational use or up to 24 grams of concentrated cannabis, such as oils derived from a cannabis plant (https://cnw.fm/1gF1p). With the state’s cannabis industry expected to begin…

Continue Reading

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000